ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Specialty Chemicals

Croda injects $82 million into adjuvants

by Alex Scott
January 7, 2019 | APPEARED IN VOLUME 97, ISSUE 1

 

Croda International has agreed to purchase Brenntag Biosector, a Danish adjuvants producer, from chemical distributor Brenntag Nordic for about $82 million. Biosector has a portfolio of aluminum- and saponin-based adjuvants, used to enhance the effectiveness of human and animal vaccines. The purchase includes a production facility in Frederikssund, Denmark. Croda already produces inert drug ingredients, known as excipients.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment